Search

Your search keyword '"Najafzadeh MJ"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Najafzadeh MJ" Remove constraint Author: "Najafzadeh MJ"
138 results on '"Najafzadeh MJ"'

Search Results

1. Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency

2. Comparative genomics of sibling species of Fonsecaea associated with human chromoblastomycosis

3. Genome sequence of Fonsecaea multimorphosa CBS 980.96, causal agent of feline cerebral phaeohyphomycosis

4. Draft genome sequence of Fonsecaea nubica (CBS 269.64), causative agent of human chromoblastomycosis

5. Mucormycosis in ImmunocompromisedPpatients

6. Phylogenetic Findings Suggest Possible New Habitat and Routes of Infection of Human Eumyctoma

7. Molecular epidemiology of Fonsecaea species.

8. Epidemiology of Candidemia in Mashhad, Northeast Iran: A Prospective Multicenter Study (2019-2021).

9. The prevalence of metabolically healthy obesity and its transition into the unhealthy state: A 5-year follow-up study.

10. Eosinophils and chronic obstructive pulmonary diseases (COPD) in hospitalized COVID-19 patients.

11. COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance.

12. Multisystem inflammatory syndrome in children (MIS-C) post-COVID-19 in Iran: clinical profile, cardiac features, and outcomes.

15. Myopia Progression during the COVID-19 Era: A Systematic Review and Meta-analysis.

16. The relationship between vitamin D and short-term blood pressure variability.

17. Investigating the Relationship between Carotid Intima-Media Thickness (CIMT), Opium Addiction, and Components of the Metabolic Syndrome.

18. Investigating the relationship between haematological parameters and metabolic syndrome: A population-based study.

19. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.

20. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.

21. Streptococcus-related acute suppurative thyroiditis in a COVID-19-positive child: A rare case report.

22. Epidemiology and Antifungal Susceptibility of Candida Species Isolated from 10 Tertiary Care Hospitals in Iran.

23. The Therapeutic Effects of Nigella sativa on Skin Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

24. Pneumoscrotum, a Rare Presentation of Barotrauma Following Noninvasive Positive Pressure Ventilation in Patients with Severe COVID-19 Pneumonia:.

25. Hyperuricaemia and its association with other risk factors for cardiovascular diseases: A population-based study.

26. COMPARISON OF ULTRASOUND-GUIDED ERECTOR SPINAE PLANE BLOCK WITH INTERCOSTAL NERVE BLOCK FOR TRAUMA-ASSOCIATED CHEST WALL PAIN.

27. In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant Fusarium Strains.

28. Phaeohyphomycosis caused by Neoscytalidiumdimidiatum in a COVID-19 patient.

29. Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.

30. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of Aspergillus sections Flavi and Nigri .

31. Update on dermatophytosis in Mashhad, Northeastern Iran, emergence of infection with Trichophyton persicum .

32. In vitro activity of eight antifungal drugs against Chaetomiaceae.

33. In vitro activities of 8 antifungal drugs against 126 clinical and environmental Exophiala isolates.

34. Discovery of New Trichophyton Members, T. persicum and T. spiraliforme spp. nov., as a Cause of Highly Inflammatory Tinea Cases in Iran and Czechia.

35. First report of invasive Aspergillus rhinosinusitis in a critically ill COVID-19 patient affected by acute myeloid leukemia, northeastern Iran.

36. Molecular Diversity of Aspergilli in Two Iranian Hospitals.

37. Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs.

38. Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.

39. Environmental Screening of Fonsecaea Agents of Chromoblastomycosis Using Rolling Circle Amplification.

40. DNA sequence analysis of keratinophilic fungi isolated from livestock stables in the East of Iran.

41. Environmental prospecting of black yeast-like agents of human disease using culture-independent methodology.

42. Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.

43. Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates.

44. Targeting novel genes for simultaneous detection of five fungal and bacterial agents from BAL samples using multiplex PCR assay.

45. Phylogenetic Analysis of Clinically Relevant Fusarium Species in Iran.

46. Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates.

47. Low in vitro activity of sertaconazole against clinical isolates of dermatophyte.

48. Trichophyton mentagrophytes and T interdigitale genotypes are associated with particular geographic areas and clinical manifestations.

50. Comparative pathogenicity of opportunistic black yeasts in Aureobasidium.

Catalog

Books, media, physical & digital resources